Skip to main content
Livermore
Livermore
ZHEN

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

BEAM holding history

Beam Therapeutics Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of BEAM by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−111,510−100.0%Sold outHolders
Q4 2025111,510$3.09M0.1%−2,777,778−96.1%ReducedHolders
Q3 20252,889,288$70.1M1.5%00.0%UnchangedHolders
Q2 20252,889,288$49.1M1.1%+493,358+20.6%AddedHolders
Q1 20252,395,930$46.8M1.0%+877,809+57.8%AddedHolders
Q4 20241,518,121$37.6M0.7%00.0%UnchangedHolders
Q3 20241,518,121$37.2M0.6%+100,000+7.1%AddedHolders
Q2 20241,418,121$33.2M0.5%+225,000+18.9%AddedHolders
Q1 20241,193,121$39.4M0.6%+498,300+71.7%AddedHolders
Q4 2023694,821$18.9M0.3%00.0%UnchangedHolders
Q3 2023694,821$16.7M0.3%−600−0.1%ReducedHolders
Q2 2023695,421$22.2M0.3%00.0%UnchangedHolders
Q1 2023695,421$21.3M0.3%−1,300−0.2%ReducedHolders
Q4 2022696,721$27.2M0.4%+125,000+21.9%AddedHolders
Q3 2022571,721$27.2M0.4%−900−0.2%ReducedHolders
Q2 2022572,621$22.2M0.3%−10,200−1.8%ReducedHolders
Q1 2022582,821$33.4M0.4%−30,000−4.9%ReducedHolders
Q4 2021612,821$48.8M0.5%00.0%UnchangedHolders
Q3 2021612,821$53.3M0.5%00.0%UnchangedHolders
Q2 2021612,821$78.9M0.8%+46,000+8.1%AddedHolders
Q1 2021566,821$45.4M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.